Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

CDC Responds to Ebola Outbreak in Democratic Republic of Congo and Uganda

The Centers for Disease Control and Prevention activated its response to an Ebola outbreak affecting the Democratic Republic of Congo and Uganda. The agency is providing assistance to international health organizations.

06/12/2026 · South Carolina edition

Advertisement

Advertisement

The Centers for Disease Control and Prevention is mobilizing resources to address an Ebola outbreak in the Democratic Republic of Congo and Uganda. The agency aims to support ongoing international efforts to control the spread of the virus.

The CDC has not released specific details regarding the aid being provided, but the mobilization suggests a multi-faceted approach, likely including technical assistance, personnel deployment, and logistical support, working in conjunction with local governments and global health partners.

Ebola virus disease, a severe and often fatal illness, spreads through direct contact with bodily fluids of infected individuals and animals. Symptoms can include fever, headache, muscle pain, vomiting, and hemorrhage.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102445 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from South Carolina

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from South Carolina

health

Florida Reports Largest Continental U.S. Dengue Outbreak in Decades

Florida has recorded its most significant dengue outbreak in decades across the continental United States. Health experts attribute the rise in cases to ongoing mosquito activity and evolving climate patterns. They anticipate a potential increase in localized outbreaks.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories